SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 50,89 | 77,15 | 2020-03-31 |
| FV Group AB | 7,15 | 3,33 | 2020-03-31 |
| Fredrik Herslow | 4,40 | 2,05 | 2020-03-31 |
| Jan Zetterberg | 3,62 | 1,68 | 2020-03-31 |
| Avanza Pension | 2,85 | 1,33 | 2020-03-31 |
| Frantek Invest AB | 2,19 | 1,02 | 2020-03-31 |
| Understödsföreningen Prometheus Pension | 1,88 | 0,88 | 2020-03-31 |
| Helena Lomberg | 1,68 | 0,78 | 2020-03-31 |
| Nordnet Pensionsförsäkring | 1,61 | 0,75 | 2020-03-31 |
| Björn Wullt | 0,74 | 0,35 | 2020-03-31 |
2020-08-27 Bokslutskommuniké 2020